Yvonne Genzel

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 20

Top Topics

Endoplasmic Reticulum Stress

Computed Tomography

Top Venues

Applied microbiology and biotechnology

Human vaccines & immunotherapeutics

Engineering in life sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Tilia Zinnecker, Najd Badri, Diogo Araujo, Kristin Thiele, Udo Reichl, Yvonne Genzel
From single-cell cloning to high-yield influenza virus production - implementing advanced technologies in vaccine process development. Engineering in life sciences 24 (4) (2024)
Yvonne Genzel, Lars Pelz, Cristina A T Silva, Béla Brühlmann, Charles Hill, Jennifer Altomonte, Amine A Kamen, Udo Reichl, Yvonne Genzel
Production of recombinant vesicular stomatitis virus-based vectors by tangential flow depth filtration. Applied microbiology and biotechnology 108 (1) (2024)
Yvonne Genzel, Ozeir Kazemi, Ji Ma, Ingo Jordan, Volker Sandig, Jasmine Paulissen, Winnie Kerstens, Hendrik-Jan Thibaut, Udo Reichl, Kai Dallmeier, Yvonne Genzel
Parallel Multifactorial Process Optimization and Intensification for High-Yield Production of Live YF17D-Vectored Zika Vaccine. Vaccines 12 (7) (2024)
Yvonne Genzel, Ozeir Kazemi, Ji Ma, Ingo Jordan, Volker Sandig, Jasmine Paulissen, Winnie Kerstens, Hendrik-Jan Thibaut, Udo Reichl, Kai Dallmeier, Yvonne Genzel
Parallel Multifactorial Process Optimization and Intensification for High-Yield Production of Live YF17D-Vectored Zika Vaccine. Vaccines 12 (7) (2024)
Yvonne Genzel, Lars Pelz, Cristina A T Silva, Béla Brühlmann, Charles Hill, Jennifer Altomonte, Amine A Kamen, Udo Reichl, Yvonne Genzel
Production of recombinant vesicular stomatitis virus-based vectors by tangential flow depth filtration. Applied microbiology and biotechnology 108 (1) (2024)
Tilia Zinnecker, Udo Reichl, Yvonne Genzel
Innovations in cell culture-based influenza vaccine manufacturing - from static cultures to high cell density cultivations. Human vaccines & immunotherapeutics 20 (1) (2024)
Tilia Zinnecker, Najd Badri, Diogo Araujo, Kristin Thiele, Udo Reichl, Yvonne Genzel
From single-cell cloning to high-yield influenza virus production - implementing advanced technologies in vaccine process development. Engineering in life sciences 24 (4) (2024)
Yvonne Genzel, Lars Pelz, Cristina A T Silva, Béla Brühlmann, Charles Hill, Jennifer Altomonte, Amine A Kamen, Udo Reichl, Yvonne Genzel
Production of recombinant vesicular stomatitis virus-based vectors by tangential flow depth filtration. Applied microbiology and biotechnology 108 (1) (2024)
Tilia Zinnecker, Udo Reichl, Yvonne Genzel
Innovations in cell culture-based influenza vaccine manufacturing - from static cultures to high cell density cultivations. Human vaccines & immunotherapeutics 20 (1) (2024)
Yvonne Genzel, Ozeir Kazemi, Ji Ma, Ingo Jordan, Volker Sandig, Jasmine Paulissen, Winnie Kerstens, Hendrik-Jan Thibaut, Udo Reichl, Kai Dallmeier, Yvonne Genzel
Parallel Multifactorial Process Optimization and Intensification for High-Yield Production of Live YF17D-Vectored Zika Vaccine. Vaccines 12 (7) (2024)
Tilia Zinnecker, Udo Reichl, Yvonne Genzel
Innovations in cell culture-based influenza vaccine manufacturing - from static cultures to high cell density cultivations. Human vaccines & immunotherapeutics 20 (1) (2024)
Marc D Hein, Daniel Kazenmaier, Yasemin van Heuvel, Tanya Dogra, Maurizio Cattaneo, Sascha Y Kupke, Jörn Stitz, Yvonne Genzel, Udo Reichl
Production of retroviral vectors in continuous high cell density culture. Applied microbiology and biotechnology (2023)
Marion Möckel, Nino Baldok, Thorsten Walles, Roland Hartig, Andreas J Müller, Udo Reichl, Yvonne Genzel, Heike Walles, Cornelia Wiese-Rischke
Human 3D Airway Tissue Models for Real-Time Microscopy: Visualizing Respiratory Virus Spreading. Cells 11 (22) (2022)
Yvonne Genzel, Fabian Kortum, Karim Jaén Chavez, Ingo Jordan, Volker Sandig, Udo Reichl, Jennifer Altomonte, Yvonne Genzel
Cell-line screening and process development for a fusogenic oncolytic virus in small-scale suspension cultures. Applied microbiology and biotechnology 106 (13-16) (2022)
Thomas Bissinger, Yixiao Wu, Pavel Marichal-Gallardo, Dietmar Riedel, Xuping Liu, Yvonne Genzel, Wen-Song Tan, Udo Reichl
Towards integrated production of an influenza A vaccine candidate with MDCK suspension cells. Biotechnology and bioengineering 118 (10) (2021)
Sabine Pech, Markus Rehberg, Robert Janke, Dirk Benndorf, Yvonne Genzel, Thilo Muth, Albert Sickmann, Erdmann Rapp, Udo Reichl
Tracking changes in adaptation to suspension growth for MDCK cells: cell growth correlates with levels of metabolites, enzymes and proteins. Applied microbiology and biotechnology 105 (5) (2021)
Alexander Pralow, Marcus Hoffmann, Terry Nguyen-Khuong, Markus Pioch, René Hennig, Yvonne Genzel, Erdmann Rapp, Udo Reichl
Comprehensive N-glycosylation analysis of the influenza A virus proteins HA and NA from adherent and suspension MDCK cells. The FEBS journal 288 (16) (2021)
Marc D Hein, Anshika Chawla, Maurizio Cattaneo, Sascha Y Kupke, Yvonne Genzel, Udo Reichl
Cell culture-based production of defective interfering influenza A virus particles in perfusion mode using an alternating tangential flow filtration system. Applied microbiology and biotechnology 105 (19) (2021)
Gwendal Gränicher, Felipe Tapia, Ilona Behrendt, Ingo Jordan, Yvonne Genzel, Udo Reichl
Production of Modified Vaccinia Ankara Virus by Intensified Cell Cultures: A Comparison of Platform Technologies for Viral Vector Production. Biotechnology journal 16 (1) (2020)
Alexander Nikolay, Joris de Grooth, Yvonne Genzel, Jeffery A Wood, Udo Reichl
Virus harvesting in perfusion culture: Choosing the right type of hollow fiber membrane. Biotechnology and bioengineering 117 (10) (2020)